Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK104 in Subjects With Advanced Solid Tumors
Condition(s):Advanced CancerLast Updated:March 9, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced CancerLast Updated:March 9, 2018Unknown status
Condition(s):Healthy; PharmacokineticsLast Updated:April 26, 2010Completed
Condition(s):Renal Cell CarcinomaLast Updated:October 19, 2020Terminated
Condition(s):Mucosal MelanomaLast Updated:September 30, 2020Active, not recruiting
Condition(s):Metastatic Urothelial CancerLast Updated:March 4, 2020Completed
Condition(s):Mild Neurocognitive DisorderLast Updated:April 15, 2022Recruiting
Condition(s):StrokeLast Updated:June 24, 2013Unknown status
Condition(s):Immune Thrombocytopenic PurpuraLast Updated:February 12, 2019Completed
Condition(s):Pulmonary Disease, Chronic ObstructiveLast Updated:September 4, 2014Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:January 9, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.